Alf Goebel, Advanco

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.

Examining the impact of 'new-edge technology'—and Industry 4.0—on pharma track-and-trace warehouse operations

With the delivery of Covid-19 booster shots in full swing, how does this effort compare to the initial vaccine distribution—and is the pharma supply chain adapting accordingly?

How the pharma serialization and track-and-trace sector can be better prepared, should the world be unlucky enough to experience another global crisis